To study the significance of PRG4-CD44 in mitigating synovitis and synovial hyperplasia in RA, Al-Sharif et al. demonstrated that recombinant human PRG4 (rhPRG4) competes with HA in binding to CD44 in a concentration-dependent mechanism [40]. This evidence concerns the gene PRG4 and rheumatoid arthritis.